Voleon Capital Management LP Sells 5,521 Shares of iRadimed Corporation $IRMD

Key Points

• Voleon Capital Management LP reduced its stakes in iRadimed Corporation by 37.8%, holding 9,095 shares valued at $477,000, as revealed in its recent SEC filing.
• iRadimed's stock recently increased by 0.1%, with a market cap of $914.44 million and a price-to-earnings ratio of 44.38.
• The company announced a quarterly dividend of $0.17, resulting in a 0.9% dividend yield, with a payout ratio of 41.98%.

Voleon Capital Management LP trimmed its holdings in shares of iRadimed Corporation (NASDAQ:IRMD - Free Report) by 37.8% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 9,095 shares of the medical equipment provider's stock after selling 5,521 shares during the period. Voleon Capital Management LP owned approximately 0.07% of iRadimed worth $477,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also recently bought and sold shares of the business. Vanguard Group Inc. raised its position in iRadimed by 3.3% during the first quarter. Vanguard Group Inc. now owns 554,451 shares of the medical equipment provider's stock valued at $29,098,000 after buying an additional 17,640 shares during the period. Copeland Capital Management LLC raised its position in iRadimed by 3.2% during the first quarter. Copeland Capital Management LLC now owns 490,544 shares of the medical equipment provider's stock valued at $25,744,000 after buying an additional 14,981 shares during the period. Goldman Sachs Group Inc. raised its position in iRadimed by 1.1% during the first quarter. Goldman Sachs Group Inc. now owns 169,387 shares of the medical equipment provider's stock valued at $8,889,000 after buying an additional 1,821 shares during the period. Northern Trust Corp raised its position in iRadimed by 7.3% during the fourth quarter. Northern Trust Corp now owns 143,069 shares of the medical equipment provider's stock valued at $7,869,000 after buying an additional 9,722 shares during the period. Finally, Bank of New York Mellon Corp grew its stake in iRadimed by 1.6% in the first quarter. Bank of New York Mellon Corp now owns 101,665 shares of the medical equipment provider's stock valued at $5,335,000 after purchasing an additional 1,557 shares in the last quarter. 92.34% of the stock is owned by institutional investors and hedge funds.

iRadimed Trading Up 1.1%

NASDAQ IRMD traded up $0.81 on Monday, reaching $72.08. The stock had a trading volume of 15,029 shares, compared to its average volume of 44,287. The business has a 50 day moving average price of $66.07 and a 200 day moving average price of $58.51. iRadimed Corporation has a 1 year low of $46.86 and a 1 year high of $74.43. The company has a market capitalization of $916.86 million, a price-to-earnings ratio of 44.49 and a beta of 1.01.

iRadimed Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Thursday, August 28th. Shareholders of record on Monday, August 18th were paid a $0.17 dividend. The ex-dividend date was Monday, August 18th. This represents a $0.68 dividend on an annualized basis and a yield of 0.9%. iRadimed's payout ratio is 41.98%.

Insider Buying and Selling

In other iRadimed news, Director Monty K. Allen sold 1,102 shares of the business's stock in a transaction dated Wednesday, August 6th. The stock was sold at an average price of $69.10, for a total value of $76,148.20. Following the transaction, the director owned 19,898 shares in the company, valued at $1,374,951.80. The trade was a 5.25% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. 36.80% of the stock is owned by company insiders.

iRadimed Company Profile

IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging compatible medical devices. It also provides a non-magnetic Intravenous infusion pump system that is specifically designed for use during MRI procedures. The company was founded by Roger Susi in July 1992 and is headquartered in Winter Springs, FL.